Paolo Uva

Paolo Uva
Paolo Uva is a researcher in the Bioinformatics group of CRS4. He obtained his Laurea (MSc) degree in Biology in 1999 from the University La Sapienza in Rome, Italy and then he moved in France where he received in 2002 a PhD degree in molecular phylogeny from the University of Tours, France. In 2004 he obtained a Master in Bioinformatics at the University of Geneva/Lausanne, Switzerland. As a postdoctoral scientist, he worked at the University La Sapienza in Rome, Italy (2004-2005) on the analysis of genome-wide expression data before joining in 2006 the Istituto di Ricerche di Biologia Molecolare (IRBM, owned by Merck & Co. Inc), Rome where he focused on microarray design, identification of molecular signatures in cancer and development of molecular biomarkers. In 2009 he moved to CRS4 where he concentrated on the analysis of data generated with Next Generation Sequencing technology. Current research activities are oriented towards the identification of the genetic basis of inherited disorders using exome sequencing. His research is published in international refereed journals and conferences.
Position

Researcher

Contacts

Email

paolo.uva@crs4.it

Phones

Fax

Google Scholar

LbzrhrUAAAAJ

e3c44c42-99fc-1032-95fe-0030485a3848

Publications


Projects


Questo sito utilizza cookie tecnici e assimilati. Possono essere presenti anche cookie profilazione di terze parti. Se vuoi saperne di piĆ¹ o negare il consenso a tutti o ad alcuni cookie leggi l'informativa completa. Proseguendo nella navigazione (anche con il semplice scrolling) acconsenti all'uso dei cookie. This site uses technical and anonymized analytics cookies only. There may also be profiling third-party cookies. Please read the cookie information page to learn more about how we use cookies or blocking them. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close